Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
MMWR supplements is Scopus-indexed (Q1, CiteScore 45.5). Published by Epidemiology Program Office.
Checked against the index lists dated .
ISSN 2380-8942Verify ISSN ↗2380-8950Verify ISSN ↗
Publisher: Epidemiology Program Office
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 6 / 669 | 99th | Q1 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–2024 (also 2020, 2016), best quartile Q1, CiteScore 45.5.
MMWR supplements is Q1 in Medicine (all) (rank 6 of 669), by CiteScore 2025.
MMWR supplements is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 45.5, quartile Q1, 99th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 6.859, quartile Q1, with an H-index of 33.
MMWR supplements is published by Epidemiology Program Office. Its print ISSN is 2380-8942 and its online ISSN is 2380-8950.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
MMWR supplements has an h-index of 40 and a 2-year mean of 28.82 citations per paper (OpenAlex). Its Scopus CiteScore is 45.5, quartile Q1. On 2-year citations it ranks #4 of 646 Scopus journals in Medicine (all).
MMWR supplements published 22 papers in 2024; its busiest recent year was 2016 with 25. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 39 research articles (2022–2024), authors are most often from United States (100%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.